Nutranomics Enters Non-Disclosure Non-Circumvent Agreement with European OTC Drug and Dietary Supplement Distributor Novascon Pharmaceuticals

Nov 19, 2013, 04:00 ET from Nutranomics, Inc.

DRAPER, Utah, Nov. 19, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that the Company has entered into a non-disclosure and non-circumvent agreement with Novascon Pharmaceuticals Sp. z o.o., a Warsaw based mid-sized OTC/ Dietary Supplement and Pharmaceutical company with nationwide distribution in Poland.

"With the signing of this agreement, Nutranomics is free to discuss its formulas and patented information in detail with this excellent potential Eastern European distribution partner," stated Nutranomics' Eastern European Sales Director, Honorata Zapasnik.  "I anticipate that we will work closely with Novascon over the next several weeks to review and evaluate each other's current product lineups, potential synergies, and new product development opportunities."

Founded in 2007, Novascon Pharmaceuticals Sp. z o.o. specializes in the development and marketing of innovative nutritional supplements and dietetic foodstuffs for children and adults.  Novascon combines the latest technology with the highest quality ingredients, to offer nearly thirty innovative products with formulations containing herbal extracts to support the body for a wide range of uses from probiotics and vitamins to nervous system support.  Novascon is a member of the National Council for Supplements and Nutritional Foods and is ISO 9001:2008 Certified.

Dr. Gibbs, CEO of Nutranomics, concluded, "I look forward to expanding our footprint throughout the Eastern European market.  These rapidly developing markets are looking for innovative and effective ways to curb their ever increasing health care costs, and clinically proven herbs and dietary supplements are the sustainable cost effective answer that many patients and medical professionals are turning to."

About Nutranomics

Nutranomics is a publicly traded company engaged in research and development of nutritional food products.  In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public.  Nutranomics has also produced formulas for hundreds of other companies.  Nutranomics' mission is to increase human health and longevity through education and self-awareness.  The Company has sales representatives throughout North America and Asia.

For further information regarding Nutranomics, Inc., please contact our investor relations representatives at or call toll-free (888) 616-3999.

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements."  Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future.  Such forward-looking statements include receiving purchase orders from Novascon or any other current and/or future potential customers, and expansion throughout Europe.  Actual results could differ from those projected in any forward-looking statements due to numerous factors.  Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions.  These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States.  Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.  Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at  These statements have not been evaluated by the Food and Drug Administration.  These products are not intended to diagnose, treat, cure or prevent any disease.

SOURCE Nutranomics, Inc.